Cargando…

Analysis of local recurrence causes in uveal melanoma patients treated with (125)I brachytherapy – a single institution study

PURPOSE: To perform a retrospective analysis of factors which might affect the occurrence of a relapse of uveal melanoma after (125)I brachytherapy. MATERIAL AND METHODS: The analysis concerned 343 patients treated in the years 2001-2012. The effect on local recurrence of such factors as patient’s s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kowal, Joanna, Markiewicz, Anna, Dębicka-Kumela, Magdalena, Bogdali, Anna, Jakubowska, Barbara, Karska-Basta, Izabella, Romanowska-Dixon, Bożena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964341/ https://www.ncbi.nlm.nih.gov/pubmed/31969914 http://dx.doi.org/10.5114/jcb.2019.90985

Ejemplares similares

Outcomes of I-125 brachytherapy for uveal melanomas depending on irradiation dose applied to the tumor apex – a single institution study
por: Kowal, Joanna, et al.
Publicado: (2018)

Brachytherapy or enucleation in ring melanoma patients: which is better? Preliminary results of the authors’ own experiences
por: Markiewicz, Anna, et al.
Publicado: (2021)

Deterioration of Visual Acuity after Brachytherapy and Proton Therapy of Uveal Melanoma, and Methods of Counteracting This Complication Based on Recent Publications
por: Jarczak, Jakub, et al.
Publicado: (2023)

Ophthalmic applicator displacement as a method of treating large diffuse uveal melanomas
por: Markiewicz, Anna, et al.
Publicado: (2023)

Sex Differences in the Treatment of Uveal Melanoma in a Group of 1336 Patients
por: Romanowska-Dixon, Bożena, et al.
Publicado: (2023)

Imbalance in the Levels of Angiogenic Factors in Patients with Acute and Chronic Central Serous Chorioretinopathy
por: Karska-Basta, Izabella, et al.
Publicado: (2021)

Association between Subjective and Objective Assessment of Enucleation Outcome Depending on the Presence of an Orbital Implant in Patients with Uveal Melanoma
por: Pociej-Marciak, Weronika, et al.
Publicado: (2022)

Regression patterns of uveal melanoma after iodine-125 plaque brachytherapy
por: Fang, Rui, et al.
Publicado: (2021)

Ruthenium brachytherapy for uveal melanoma – single institution experience
por: Rospond-Kubiak, Iwona, et al.
Publicado: (2017)

Ocular Toxoplasmosis Associated with Unilateral Pigmentary Retinopathy That May Mimic Retinitis Pigmentosa: Diagnostic Dilemmas
por: Karska-Basta, Izabella, et al.
Publicado: (2021)

Outcomes and Control Rates for I-125 Plaque Brachytherapy for Uveal Melanoma: A Community-Based Institutional Experience
por: Wagner, Aaron, et al.
Publicado: (2014)

Silicone Oil and Iodine-125 Brachytherapy for Uveal Melanoma in High-Risk Patients
por: Lyons, Lance J, et al.
Publicado: (2019)

Acute Macular Neuroretinopathy in a Patient with Retinal Vascular Tortuosity
por: Karska-Basta, Izabella, et al.
Publicado: (2021)

Intra-operative ocular ultrasonography of iodine-125 brachytherapy plaques in patients with uveal melanoma
por: Ces, Antonio Piñeiro, et al.
Publicado: (2021)

Sudden Visual Deterioration as the First Symptom of Chronic Kidney Failure
por: Pociej-Marciak, Weronika, et al.
Publicado: (2015)

Toxocara Optic Disc Granuloma: Deep Range Imaging Optical Coherence Tomography Findings
por: Karska-Basta, Izabella, et al.
Publicado: (2019)

The impact of selected factors on early diagnosis of multiple primary cancers in patients with uveal melanoma
por: Mierzwa-Dobranowska, Marzena, et al.
Publicado: (2013)

Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma
por: Lonngi, Marcela, et al.
Publicado: (2013)

Reduced blood flow by laser speckle flowgraphy after (125)I-plaque brachytherapy for uveal melanoma
por: Tamplin, Michelle R., et al.
Publicado: (2022)

Altered plasma cytokine levels in acute and chronic central serous chorioretinopathy
por: Karska‐Basta, Izabella, et al.
Publicado: (2020)

Quality of life of patients with central serous chorioretinopathy – a major cause of vision threat among middle-aged individuals
por: Karska-Basta, Izabella, et al.
Publicado: (2020)

Genetic Variants of Complement Factor H Y402H (rs1061170), C2 R102G (rs2230199), and C3 E318D (rs9332739) and Response to Intravitreal Anti-VEGF Treatment in Patients with Exudative Age-Related Macular Degeneration
por: Kubicka-Trząska, Agnieszka, et al.
Publicado: (2022)

Brachytherapy of Uveal Melanomas with Ruthenium-106 Plaques
por: Belaïd, Asma, et al.
Publicado: (2016)

Acute Zonal Occult Outer Retinopathy in a Patient Suffering from Epilepsy: Five-Year Follow-Up
por: Karska-Basta, Izabella, et al.
Publicado: (2021)

Diagnostic and Therapeutic Challenges in a Patient with Radiation Retinopathy Complicated by Corticosteroid-Induced Central Serous Chorioretinopathy
por: Chrząszcz, Michał, et al.
Publicado: (2022)

(103)Pd versus (125)I ophthalmic plaque brachytherapy: preoperative comparative radiation dosimetry for 319 uveal melanomas
por: Finger, Paul T., et al.
Publicado: (2014)

Temporal Relationship Between Visual Field, Retinal and Microvascular Pathology Following (125)I-Plaque Brachytherapy for Uveal Melanoma
por: Tamplin, Michelle R., et al.
Publicado: (2021)

A study comparing baseline and best-corrected visual acuity after iodine-125 episcleral brachytherapy in uveal melanoma
por: Miguel, David, et al.
Publicado: (2023)

Preliminary results of proton radiotherapy for choroidal melanoma – the Kraków experience
por: Sas-Korczyńska, Beata, et al.
Publicado: (2014)

Amelanotic Uveal Melanomas Evaluated by Indirect Ophthalmoscopy Reveal Better Long-Term Prognosis Than Pigmented Primary Tumours—A Single Centre Experience
por: Markiewicz, Anna, et al.
Publicado: (2022)

Forty-year prognosis after plaque brachytherapy of uveal melanoma
por: Stålhammar, Gustav
Publicado: (2020)

A Prognostic Score for the Prediction of Local Treatment Failure in Plaque Brachytherapy of Uveal Melanoma
por: Kal Omar, Ruba, et al.
Publicado: (2022)

Brachytherapy for patients with uveal melanoma: historical perspectives and future treatment directions
por: Brewington, Beatrice Y, et al.
Publicado: (2018)

Long-Term Outcomes in Uveal Melanoma After Ruthenium-106 Brachytherapy
por: Cennamo, Gilda, et al.
Publicado: (2022)

Clinical Outcomes after Surgical Resection Combined with Brachytherapy for Uveal Melanomas
por: Relimpio-López, Isabel, et al.
Publicado: (2022)

Changes in Plasma VEGF and PEDF Levels in Patients with Central Serous Chorioretinopathy
por: Chrząszcz, Michał, et al.
Publicado: (2021)

Three-year outcomes of uveal melanoma treated with intra-operative ultrasound-guided iodine-125 brachytherapy using custom-built eye plaques
por: Wong, Andrew J., et al.
Publicado: (2022)

Vitamin D receptors (VDR), hydroxylases CYP27B1 and CYP24A1 and retinoid-related orphan receptors (ROR) level in human uveal tract and ocular melanoma with different melanization levels
por: Markiewicz, Anna, et al.
Publicado: (2019)

(106)Ruthenium eye plaque brachytherapy in the management of medium sized uveal melanoma
por: Jiang, Ping, et al.
Publicado: (2020)

Staged Eye-Plaque Brachytherapy: A Novel Approach for Large Uveal Melanoma
por: Chevli, Neil, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c5nu7p8labnh88jddlr00bvhd7